Biopharmaceutical company Genelabs Technologies of Redwood City, Calif., has added Sequenom CSO Charles Cantor to its scientific advisory board. Cantor has been a scientific consultant to the company for 15 years.
Formerly the director of the Department of Energy’s human genome center at Lawrence Berkeley Laboratory, he still participates in the Human Genome Project through its advisory committees and review boards.
Cantor is also a professor in Boston University’s department of biomedical engineering and biophysics and is director of the university’s center for advanced biotechnology.
Enchira Biotechnology of The Woodlands, Tex., has elected Anthony Gorry, professor of management and computer science at Rice University, to its board of directors.
In addition to his posts at Rice, Gorry is also a director of the W M Keck Center for Computational Biology, a joint endeavor of Rice, Baylor College of Medicine, and the University of Houston. There, he directs a training grant on computational biology funded by the National Library of Medicine.
Gorry also serves on the board of Gene Logic.
Biobase, a provider of databases on gene regulation, has named Peter Lotz as CFO. Lotz formerly held various senior management positions at Hoechst and Aventis Pharmaceuticals.